Full Press Release Details
Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer.
SGMT
Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer
Key Takeaway: Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer
Price reaction · baseline $4.32 (2024-05-03 close) · 1 other SGMT headline(s) in the window, move may be shared
day 0 close
-0.9%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+110%
120-day peak, hindsight
Typical move
5.7%
average across 12 past catalysts
Cash runway
~69 mo
Minimal dilution risk
Lead asset
TVB-2640
Phase 2 · Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease